November 8, 2014
Notes: Jolivot, Romuald
Int J Biomed Imaging. 2013;2013:978289. doi: 10.1155/2013/978289. Epub 2013 Sep 18.
Author Address: National Electronic and Computer Technology Center, 112 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Klong Luang, Pathumthani 12120, Thailand.
Reference Type: Journal Article
Record Number: 4510Author: Journet-Tollhupp, J., Grange, F. and Bernard, P.
Title: [Changes in mortality in the Reims University Hospital Dermatology Department (1996-2009)]
Journal: Ann Dermatol Venereol
Short Title: [Changes in mortality in the Reims University Hospital Dermatology Department (1996-2009)]
Alternate Journal: Annales de dermatologie et de venereologie
ISSN: 0151-9638 (Print)
Original Publication: Evolution de la mortalite dans le service de dermatologie du CHU de Reims (1996-2009).
Accession Number: 23395489
Aged, 80 and over
Cause of Death
Hospital Departments/*statistics & numerical data
Hospitals, University/*statistics & numerical data
Abstract: BACKGROUND: End-of-life care is becoming a daily concern of French dermatology departments. The aim of this single-centre retrospective study was to assess changes in mortality and end-of-life care in a university dermatology department over a 14-year period. PATIENTS AND METHODS: The medical records of all patients dying in our dermatology department from 1996 to 2009 were studied retrospectively. A descriptive analysis was performed together with a comparison between the two periods demarcated by the institution of the French National Cancer Plan at the end of 2002. RESULTS: The number of patients dying in the department rose by 33% from 108 for period 1 (1996-2002) to 144 for period 2 (2003-2009). The majority of patients presented metastatic melanoma, with doubling of numbers between the two periods. During period 2, 40 % of patients were managed in collaboration with the mobile palliative care team. CONCLUSION: This study shows an increase in the number of deaths in a French university hospital dermatology department over the 14-year period in question, ascribable mainly to an increase in the number of patients receiving end-of-life care for metastatic melanoma. Significant changes were noted in the management of these patients with an increase in palliative care procedures.